Insider · CIK 0001867104
Ursula L Hurley
cfoofficer
Files at JBLU (JETBLUE AIRWAYS CORP). First filing Feb 19, 2025, latest Feb 19, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $113k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JBLU: JETBLUE AIRWAYS CORP
JBLUOct 9, 2026 · close 3.84
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | JETBLUE AIRWAYS CORP | $113k 15,000 shares | -26% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | JBLU JETBLUE AIRWAYS CORP | AGrant or award Restricted Stock Unitsderivative | +188,216 | - | - | 534,068 | Mar 12, 2025 |
| Feb 21, 2025 | JBLU JETBLUE AIRWAYS CORP | MOption exercise Common Stock | +57,128 | - | - | 98,961 | Feb 24, 2025 |
| Feb 21, 2025 | JBLU JETBLUE AIRWAYS CORP | FTax withholding Common Stock | -20,595 | $7.24 | $149k | 78,366 | Feb 24, 2025 |
| Feb 21, 2025 | JBLU JETBLUE AIRWAYS CORP | MOption exercise Restricted Stock Unitsderivative | -57,128 | - | - | 114,257 | Feb 24, 2025 |
| Feb 18, 2025 | JBLU JETBLUE AIRWAYS CORP | SOpen-market sale Common Stock10b5-1 | -15,000 | $7.50 | $113k | 41,833 | Feb 19, 2025 |
| Oct 31, 2024 | JBLU JETBLUE AIRWAYS CORP | AGrant or award Common Stock | +1,753 | $4.79 | $8,397 | 56,833 | Nov 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.